(Q37259233)

19 August 2017

1 reference

title

The role of new basal insulin analogues in the initiation and optimisation of insulin therapy in type 2 diabetes (English)

1 reference

19 August 2017

0 references

1 reference

1 reference

Mike A Baxter

1

1 reference

19 August 2017

language of work or name

1 reference

3 September 2008

1 reference

19 August 2017

1 reference

19 August 2017

volume

45

1 reference

19 August 2017

issue

4

1 reference

19 August 2017

page(s)

253-268

1 reference

https://scigraph.springernature.com/pub.10.1007/s00592-008-0052-9

19 August 2017

exact match

0 references

cites work

Acarbose for the prevention of diabetes, hypertension, and cardiovascular disease in subjects with impaired glucose tolerance: the Study to Prevent Non-Insulin-Dependent Diabetes Mellitus (STOP-NIDDM) Trial

1 reference

https://api.crossref.org/works/10.1007%2FS00592-008-0052-9

Crossref

reference URL

Glimepiride combined with morning insulin glargine, bedtime neutral protamine hagedorn insulin, or bedtime insulin glargine in patients with type 2 diabetes. A randomized, controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-008-0052-9

Crossref

reference URL

10.1007/S00592-008-0052-9

21 January 2018

Identifiers

DOI

1 reference

19 August 2017

1 reference